Physician

James P. Myatt, MD

According to 2025 Medicare claims, James Myatt, MD (NPI: 1871778001) practices cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is J. PHILLIP MYATT, M.D., PLLC DBA WACO HEART & VASCULAR (NPI: 1255674586; TIN: 46-2455493) and primary practice location at 76712-7919. Myatt is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Myatt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 842 traditional Medicare patients, billed 14,718 HCPCS/CPT codes, and received $1,211,570 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,296 prescription claims across 913 beneficiaries totaling $682,971 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 19 claims. Open Payments data shows 129 records totaling $8,645. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $289,120 to $1,211,570. Similarly, Part D prescription costs have risen steadily, from $199,811 to $682,971. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $25,228 and ending at $44,759.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	775	4,276	$289,120
2016	1,050	6,694	$344,163
2017	1,378	14,249	$580,326
2018	1,025	13,864	$568,108
2019	928	13,068	$860,015
2020	727	8,601	$736,207
2021	749	6,585	$754,764
2022	739	6,207	$661,668
2023	838	10,426	$937,028
2024	842	14,718	$1,211,570

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	262	2,861	$199,811
2016	378	3,948	$381,227
2017	497	5,244	$462,813
2018	520	4,785	$462,783
2019	652	5,193	$516,376
2020	653	5,020	$556,098
2021	682	4,270	$600,968
2022	738	4,231	$643,886
2023	912	5,404	$788,138
2024	913	5,296	$682,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$23,002
2016	N/R	18	$1,532
2017	N/R	22	$45,057
2018	N/R	31	$38,778
2019	14	33	$69,756
2020	N/R	N/R	N/R
2021	N/R	30	$1,471
2022	N/R	N/R	N/R
2023	N/R	19	$44,635
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	553	597	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	463	905	$85
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	272	1,915	$36
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	252	1,816	$29
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	354	521	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	313	15,501	$289,683
Xarelto	Rivaroxaban	102	4,788	$85,613
Entresto	Sacubitril/Valsartan	46	2,230	$43,964
Jardiance	Empagliflozin	31	1,800	$30,351
Vascepa	Icosapent Ethyl	56	2,520	$27,334

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	129	$8,645	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James P. Myatt, MD?

Tedicare shows public-source Medicare data for James P. Myatt, MD (NPI 1871778001), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James P. Myatt, MD have ACO affiliation data?

James P. Myatt, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James P. Myatt, MD?

James P. Myatt, MD is linked to J. PHILLIP MYATT, M.D., PLLC DBA WACO HEART & VASCULAR (billing NPI 1255674586) in the available physician profile data.

Does James P. Myatt, MD have Open Payments data?

James P. Myatt, MD has 129 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.